Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Leveraging the cognitive resilience in centenarian superagers to identify microRNA biomarkers and therapeutic targets of Alzheimer's disease
EF 2025-26
Résumé
Healthcare innovations have led to increase in life expectancy. However, age increases human predisposition to cognitive impairment and Alzheimer's disease (AD). Despite this increased risk, some individuals live up to 100 years (centenarians) and display better cognitive integrity and function compared to their peers. These centenarians are resistant or resilient to the underlying age-related brain changes that predispose to AD. Understanding the mechanisms of maintaining cognitive function into such old age may provide an opportunity to design drugs that enhance resistance/resilience to cognitive decline and AD. My research therefore focuses on two principal aims: (i) to understand the protective mechanisms that confer resilience in cognitively intact centenarians, (ii) to identify the markers of resilience and drugs that can enhance cognitive resilience in older adults.
To achieve the foregoing aims, we have obtained measures of gene functions and microRNA activity from the brains of resilient centenarians. miRNAs are important as they control many genes and biological processes at once, providing an opportunity to identify integrative marker of resilience and drug target. Using mathematical methods, we will determine which clusters of genes are associated with resilience. Then, we will identify the miRNAs that control the co-operative functions of these clusters. Furthermore, we will identify the biological processes that underlie resilience and the miRNAs controlling these groups of processes. The miRNAs that concurrently control clusters of genes and biological processes will be prioritized and tested for their therapeutic effects. This research provides an alternative approach to AD treatment by identifying resilience-promoting drugs and developing non-invasive markers of resilience.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
537842
Name
Adewale Quadri A
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Leveraging the cognitive resilience in centenarian superagers to identify microRNA biomarkers and therapeutic targets of Alzheimer's disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Alzheimer'S Disease; Centenarians; Cognitive Impairment; Cognitive Resilience; Microrna; Rna Sequencing
Abstract
Healthcare innovations have led to increase in life expectancy. However, age increases human predisposition to cognitive impairment and Alzheimer's disease (AD). Despite this increased risk, some individuals live up to 100 years (centenarians) and display better cognitive integrity and function compared to their peers. These centenarians are resistant or resilient to the underlying age-related brain changes that predispose to AD. Understanding the mechanisms of maintaining cognitive function into such old age may provide an opportunity to design drugs that enhance resistance/resilience to cognitive decline and AD. My research therefore focuses on two principal aims: (i) to understand the protective mechanisms that confer resilience in cognitively intact centenarians, (ii) to identify the markers of resilience and drugs that can enhance cognitive resilience in older adults.
To achieve the foregoing aims, we have obtained measures of gene functions and microRNA activity from the brains of resilient centenarians. miRNAs are important as they control many genes and biological processes at once, providing an opportunity to identify integrative marker of resilience and drug target. Using mathematical methods, we will determine which clusters of genes are associated with resilience. Then, we will identify the miRNAs that control the co-operative functions of these clusters. Furthermore, we will identify the biological processes that underlie resilience and the miRNAs controlling these groups of processes. The miRNAs that concurrently control clusters of genes and biological processes will be prioritized and tested for their therapeutic effects. This research provides an alternative approach to AD treatment by identifying resilience-promoting drugs and developing non-invasive markers of resilience.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Adewale, Quadri A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~